<p>Oscar Health, Inc. (NYSE:OSCR - 获取免费报告) 在周一的午盘交易中创下了新的 52 周高点。该股最高交易价格为 26.06 美元，最后交易价格为 26.5660 美元，成交量为 1727899 股。该股此前收盘价为 24.51 美元。</p>
<h2>华尔街分析师预测增长</h2>
<ul>
<li>5 只具有爆炸性上涨潜力的小型股</li>
</ul>
<p>多家研究分析师最近对 OSCR 股票发布了报告。杰富瑞金融集团将 Oscar Health 的评级从 “表现不佳” 上调至 “持有”，并在 4 月 20 日的报告中将该公司的目标价从 10.00 美元上调至 16.00 美元。华尔街 Zen 在周六的研究报告中将 Oscar Health 的评级从 “强力买入” 下调至 “买入”。雷蒙德·詹姆斯金融公司在 2 月 12 日的研究报告中将 Oscar Health 的评级从 “市场表现” 上调至 “跑赢大盘”，并设定了 18.00 美元的目标价。富国银行在周四的报告中对 Oscar Health 的股票设定了 20.00 美元的目标价，并给予该股 “等权重” 评级。最后，巴克莱在 5 月 26 日的报告中将 Oscar Health 的目标价从 21.00 美元上调至 30.00 美元，并给予该公司 “等权重” 评级。一位研究分析师对该股给予了强力买入评级，两位给予了买入评级，八位给予了持有评级，一位给予了卖出评级。根据 MarketBeat.com 的数据，该公司目前的平均评级为 “持有”，平均目标价为 20.22 美元。</p>
<p><strong>阅读我们关于 OSCR 的最新股票报告</strong></p>
<h2>Oscar Health 价格表现</h2>
<p>该股的 50 日移动平均价格为 18.39 美元，200 日移动平均价格为 16.07 美元。该公司的流动比率为 1.11，速动比率为 1.11，债务与股本比率为 0.26。该股的市值为 79.2 亿美元，市盈率为-44.70，PEG 比率为 1.71，贝塔值为 2.37。</p>
<p>Oscar Health (NYSE:OSCR - 获取免费报告) 最近在 5 月 6 日发布了季度财报。该公司报告每股收益为 2.07 美元，超出市场共识预期的 1.11 美元，超出幅度为 0.96 美元。Oscar Health 的股本回报率为-3.26%，净利润率为-0.30%。该业务在本季度的收入为 46.5 亿美元，而市场共识预期为 49 亿美元。去年同期，该公司每股收益为 0.92 美元。该公司的季度收入同比增长 52.6%。整体来看，股票研究分析师预测 Oscar Health, Inc.在本年度将发布 0.47 美元的每股收益。</p>
<h2>内部活动</h2>
<p>在其他 Oscar Health 的新闻中，内部人士 Janet Liang 在 6 月 2 日的交易中出售了 12475 股该公司的股票。股票以平均价格 21.94 美元出售，总交易额为 273,701.50 美元。交易完成后，内部人士直接持有该公司 259,057 股股票，价值约为 5,683,710.58 美元。此交易代表其持股比例下降了 4.59%。该交易已在 SEC 的备案中披露，可以通过此链接访问。该交易是在预先安排的 10b5-1 交易计划下执行的。出售是为了覆盖与股权奖励归属相关的税收扣缴义务。此外，首席会计官 Victoria Baltrus 在 6 月 2 日的交易中出售了 1523 股 Oscar Health 股票。股票以平均价格 21.94 美元出售，总交易额为 33,414.62 美元。出售后，首席会计官持有该公司 214,589 股股票，价值约为 4,708,082.66 美元。该交易代表其持股比例下降了 0.70%。该出售的披露信息可在 SEC 备案中找到。该交易是在预先安排的 10b5-1 交易计划下执行的。出售是为了覆盖与股权奖励归属相关的税收扣缴义务。在过去的 90 天里，内部人士出售了 189,660 股公司股票，价值为 4,283,140 美元。25.11% 的股票由公司内部人士持有。</p>
<h2>机构资金流入和流出</h2>
<p>多家机构投资者和对冲基金最近增加或减少了对该公司的持股。Thrive Capital Management LLC 在第四季度将其在 Oscar Health 的持股增加了 33.4%。Thrive Capital Management LLC 目前持有 6,343,617 股该公司的股票，价值为 85,258,000 美元，此前在上个季度又购买了 1,588,395 股。Baird Financial Group Inc.在第一季度购买了 Oscar Health 的新头寸，价值约为 159,000 美元。MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.在第一季度将其在 Oscar Health 的持股增加了 4.3%。MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.目前持有 215,650 股该公司的股票，价值为 2,827,000 美元，此前在该期间又收购了 8,879 股。Jones Financial Companies Lllp 在第一季度将其在 Oscar Health 的持股增加了 7,473.3%。Jones Financial Companies Lllp 目前持有 2,272 股该公司的股票，价值为 30,000 美元，此前在上个季度又购买了 2,242 股。最后，瑞银资产管理美洲有限公司的一个独特业务单位在第一季度将其在 Oscar Health 的持股增加了 39.0%。瑞银资产管理美洲有限公司的一个独特业务单位目前持有 470,590 股该公司的股票，价值为 6,169,000 美元，此前在上个季度又购买了 132,149 股。75.70% 的股票目前由机构投资者和对冲基金持有。</p>
<h2>关于 Oscar Health</h2>
<p>(获取免费报告)</p>
<p>Oscar Health，作为纽约证券交易所上市公司，股票代码为 OSCR，是一家总部位于纽约的科技驱动健康保险公司。该公司由 Mario Schlosser、Joshua Kushner 和 Kevin Nazemi 于 2012 年创立，旨在简化医疗保险覆盖并提升会员体验。Oscar 利用其专有的数字平台来简化计划注册、索赔管理和会员支持，在个人、家庭和小型团体保险市场中脱颖而出。</p>
<p>公司的主要产品包括根据《平价医疗法案》提供的交易所内个人和家庭医疗计划、交易所外计划以及医疗保险优势产品。</p>
<h2>精选文章</h2>
<ul>
<li>五只我们认为比 Oscar Health 更好的股票</li>
<li>Macy's 的表现如何：伯克希尔哈撒韦最新的购买</li>
<li>Planet Labs：回归现实</li>
<li>Docusign：又一次超预期，又一次抛售——分析师为何错了</li>
<li>Meta 推出订阅服务：具有真正增长潜力的新产品</li>
</ul>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送邮件至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1000 美元在 Oscar Health 吗？</h2>
<p>在考虑 Oscar Health 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 Oscar Health 并不在名单上。</p>
<p>尽管 Oscar Health 目前在分析师中获得了持有评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

OSCR

OSCG

OSCX

<p>Oscar Health（纽约证券交易所代码：OSCR）达到了新的 52 周高点 26.06 美元，主要受到近期分析师升级和积极的盈利意外的推动。尽管公司每股收益（EPS）为 2.07 美元，超出预期，但收入未能达到预测。尽管内部人士因税务义务进行了出售，但像 Thrive Capital 这样的机构投资者增加了他们的持股。分析师维持平均 “持有” 评级，目标价共识为 20.22 美元</p>

<p>Oscar Health, Inc. (NYSE:OSCR - Get Free Report) hit a new 52-week high during mid-day trading on Monday . The stock traded as high as $26.06 and last traded at $26.5660, with a volume of 1727899 shares changing hands. The stock had previously closed at $24.51.</p>
<div class="lb-trans"><p>Oscar Health, Inc. (NYSE:OSCR - 获取免费报告) 在周一的午盘交易中创下了新的 52 周高点。该股最高交易价格为 26.06 美元，最后交易价格为 26.5660 美元，成交量为 1727899 股。该股此前收盘价为 24.51 美元。</p>
</div><h2>Wall Street Analysts Forecast Growth</h2>
<div class="lb-trans"><h2>华尔街分析师预测增长</h2>
</div><ul>
<li>5 Small Cap Stocks With Explosive Upside Potential</li>
</ul>
<div class="lb-trans"><ul>
<li>5 只具有爆炸性上涨潜力的小型股</li>
</ul>
</div><p>A number of research analysts have recently issued reports on OSCR shares. Jefferies Financial Group upgraded Oscar Health from an &#34;underperform&#34; rating to a &#34;hold&#34; rating and lifted their price target for the company from $10.00 to $16.00 in a report on Monday, April 20th. Wall Street Zen downgraded Oscar Health from a &#34;strong-buy&#34; rating to a &#34;buy&#34; rating in a research report on Saturday. Raymond James Financial upgraded Oscar Health from a &#34;market perform&#34; rating to an &#34;outperform&#34; rating and set a $18.00 target price on the stock in a research note on Thursday, February 12th. Wells Fargo &amp; Company set a $20.00 target price on shares of Oscar Health and gave the stock an &#34;equal weight&#34; rating in a report on Thursday. Finally, Barclays raised their price target on shares of Oscar Health from $21.00 to $30.00 and gave the company an &#34;equal weight&#34; rating in a report on Tuesday, May 26th. One research analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the company presently has an average rating of &#34;Hold&#34; and an average price target of $20.22.</p>
<div class="lb-trans"><p>多家研究分析师最近对 OSCR 股票发布了报告。杰富瑞金融集团将 Oscar Health 的评级从 “表现不佳” 上调至 “持有”，并在 4 月 20 日的报告中将该公司的目标价从 10.00 美元上调至 16.00 美元。华尔街 Zen 在周六的研究报告中将 Oscar Health 的评级从 “强力买入” 下调至 “买入”。雷蒙德·詹姆斯金融公司在 2 月 12 日的研究报告中将 Oscar Health 的评级从 “市场表现” 上调至 “跑赢大盘”，并设定了 18.00 美元的目标价。富国银行在周四的报告中对 Oscar Health 的股票设定了 20.00 美元的目标价，并给予该股 “等权重” 评级。最后，巴克莱在 5 月 26 日的报告中将 Oscar Health 的目标价从 21.00 美元上调至 30.00 美元，并给予该公司 “等权重” 评级。一位研究分析师对该股给予了强力买入评级，两位给予了买入评级，八位给予了持有评级，一位给予了卖出评级。根据 MarketBeat.com 的数据，该公司目前的平均评级为 “持有”，平均目标价为 20.22 美元。</p>
</div><p><strong>Read Our Latest Stock Report on OSCR</strong></p>
<div class="lb-trans"><p><strong>阅读我们关于 OSCR 的最新股票报告</strong></p>
</div><h2>Oscar Health Price Performance</h2>
<div class="lb-trans"><h2>Oscar Health 价格表现</h2>
</div><p>The stock has a 50-day moving average price of $18.39 and a two-hundred day moving average price of $16.07. The company has a current ratio of 1.11, a quick ratio of 1.11 and a debt-to-equity ratio of 0.26. The stock has a market cap of $7.92 billion, a price-to-earnings ratio of -44.70, a PEG ratio of 1.71 and a beta of 2.37.</p>
<div class="lb-trans"><p>该股的 50 日移动平均价格为 18.39 美元，200 日移动平均价格为 16.07 美元。该公司的流动比率为 1.11，速动比率为 1.11，债务与股本比率为 0.26。该股的市值为 79.2 亿美元，市盈率为-44.70，PEG 比率为 1.71，贝塔值为 2.37。</p>
</div><p>Oscar Health (NYSE:OSCR - Get Free Report) last issued its quarterly earnings results on Wednesday, May 6th. The company reported $2.07 earnings per share for the quarter, topping the consensus estimate of $1.11 by $0.96. Oscar Health had a negative return on equity of 3.26% and a negative net margin of 0.30%.The business had revenue of $4.65 billion during the quarter, compared to the consensus estimate of $4.90 billion. During the same quarter last year, the company earned $0.92 earnings per share. The company's quarterly revenue was up 52.6% on a year-over-year basis. As a group, equities research analysts forecast that Oscar Health, Inc. will post 0.47 EPS for the current year.</p>
<div class="lb-trans"><p>Oscar Health (NYSE:OSCR - 获取免费报告) 最近在 5 月 6 日发布了季度财报。该公司报告每股收益为 2.07 美元，超出市场共识预期的 1.11 美元，超出幅度为 0.96 美元。Oscar Health 的股本回报率为-3.26%，净利润率为-0.30%。该业务在本季度的收入为 46.5 亿美元，而市场共识预期为 49 亿美元。去年同期，该公司每股收益为 0.92 美元。该公司的季度收入同比增长 52.6%。整体来看，股票研究分析师预测 Oscar Health, Inc.在本年度将发布 0.47 美元的每股收益。</p>
</div><h2>Insider Activity</h2>
<div class="lb-trans"><h2>内部活动</h2>
</div><p>In other Oscar Health news, insider Janet Liang sold 12,475 shares of the firm's stock in a transaction that occurred on Tuesday, June 2nd. The shares were sold at an average price of $21.94, for a total transaction of $273,701.50. Following the completion of the transaction, the insider directly owned 259,057 shares of the company's stock, valued at approximately $5,683,710.58. This trade represents a 4.59% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CAO Victoria Baltrus sold 1,523 shares of Oscar Health stock in a transaction that occurred on Tuesday, June 2nd. The shares were sold at an average price of $21.94, for a total transaction of $33,414.62. Following the sale, the chief accounting officer owned 214,589 shares of the company's stock, valued at approximately $4,708,082.66. The trade was a 0.70% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last ninety days, insiders sold 189,660 shares of company stock valued at $4,283,140. 25.11% of the stock is owned by corporate insiders.</p>
<div class="lb-trans"><p>在其他 Oscar Health 的新闻中，内部人士 Janet Liang 在 6 月 2 日的交易中出售了 12475 股该公司的股票。股票以平均价格 21.94 美元出售，总交易额为 273,701.50 美元。交易完成后，内部人士直接持有该公司 259,057 股股票，价值约为 5,683,710.58 美元。此交易代表其持股比例下降了 4.59%。该交易已在 SEC 的备案中披露，可以通过此链接访问。该交易是在预先安排的 10b5-1 交易计划下执行的。出售是为了覆盖与股权奖励归属相关的税收扣缴义务。此外，首席会计官 Victoria Baltrus 在 6 月 2 日的交易中出售了 1523 股 Oscar Health 股票。股票以平均价格 21.94 美元出售，总交易额为 33,414.62 美元。出售后，首席会计官持有该公司 214,589 股股票，价值约为 4,708,082.66 美元。该交易代表其持股比例下降了 0.70%。该出售的披露信息可在 SEC 备案中找到。该交易是在预先安排的 10b5-1 交易计划下执行的。出售是为了覆盖与股权奖励归属相关的税收扣缴义务。在过去的 90 天里，内部人士出售了 189,660 股公司股票，价值为 4,283,140 美元。25.11% 的股票由公司内部人士持有。</p>
</div><h2>Institutional Inflows and Outflows</h2>
<div class="lb-trans"><h2>机构资金流入和流出</h2>
</div><p>A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Thrive Capital Management LLC boosted its stake in shares of Oscar Health by 33.4% in the fourth quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company's stock worth $85,258,000 after buying an additional 1,588,395 shares during the last quarter. Baird Financial Group Inc. purchased a new position in Oscar Health during the first quarter valued at approximately $159,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in Oscar Health by 4.3% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 215,650 shares of the company's stock valued at $2,827,000 after acquiring an additional 8,879 shares during the period. Jones Financial Companies Lllp boosted its position in Oscar Health by 7,473.3% in the 1st quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company's stock worth $30,000 after purchasing an additional 2,242 shares in the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its position in Oscar Health by 39.0% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 470,590 shares of the company's stock worth $6,169,000 after purchasing an additional 132,149 shares in the last quarter. 75.70% of the stock is currently owned by institutional investors and hedge funds.</p>
<div class="lb-trans"><p>多家机构投资者和对冲基金最近增加或减少了对该公司的持股。Thrive Capital Management LLC 在第四季度将其在 Oscar Health 的持股增加了 33.4%。Thrive Capital Management LLC 目前持有 6,343,617 股该公司的股票，价值为 85,258,000 美元，此前在上个季度又购买了 1,588,395 股。Baird Financial Group Inc.在第一季度购买了 Oscar Health 的新头寸，价值约为 159,000 美元。MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.在第一季度将其在 Oscar Health 的持股增加了 4.3%。MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.目前持有 215,650 股该公司的股票，价值为 2,827,000 美元，此前在该期间又收购了 8,879 股。Jones Financial Companies Lllp 在第一季度将其在 Oscar Health 的持股增加了 7,473.3%。Jones Financial Companies Lllp 目前持有 2,272 股该公司的股票，价值为 30,000 美元，此前在上个季度又购买了 2,242 股。最后，瑞银资产管理美洲有限公司的一个独特业务单位在第一季度将其在 Oscar Health 的持股增加了 39.0%。瑞银资产管理美洲有限公司的一个独特业务单位目前持有 470,590 股该公司的股票，价值为 6,169,000 美元，此前在上个季度又购买了 132,149 股。75.70% 的股票目前由机构投资者和对冲基金持有。</p>
</div><h2>About Oscar Health</h2>
<div class="lb-trans"><h2>关于 Oscar Health</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>(获取免费报告)</p>
</div><p>Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.</p>
<div class="lb-trans"><p>Oscar Health，作为纽约证券交易所上市公司，股票代码为 OSCR，是一家总部位于纽约的科技驱动健康保险公司。该公司由 Mario Schlosser、Joshua Kushner 和 Kevin Nazemi 于 2012 年创立，旨在简化医疗保险覆盖并提升会员体验。Oscar 利用其专有的数字平台来简化计划注册、索赔管理和会员支持，在个人、家庭和小型团体保险市场中脱颖而出。</p>
</div><p>The company's primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.</p>
<div class="lb-trans"><p>公司的主要产品包括根据《平价医疗法案》提供的交易所内个人和家庭医疗计划、交易所外计划以及医疗保险优势产品。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>精选文章</h2>
</div><ul>
<li>Five stocks we like better than Oscar Health</li>
<li>What's Make of Macy's: Berkshire Hathaway's Latest Buy</li>
<li>Planet Labs: Coming Back Down to Earth</li>
<li>Docusign: Another Beat, Another Selloff—Why the Analysts Are Wrong</li>
<li>Meta Unveils Subscriptions: A New Offering With Real Growth Potential</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们认为比 Oscar Health 更好的股票</li>
<li>Macy's 的表现如何：伯克希尔哈撒韦最新的购买</li>
<li>Planet Labs：回归现实</li>
<li>Docusign：又一次超预期，又一次抛售——分析师为何错了</li>
<li>Meta 推出订阅服务：具有真正增长潜力的新产品</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送邮件至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Oscar Health Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1000 美元在 Oscar Health 吗？</h2>
</div><p>Before you consider Oscar Health, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Oscar Health 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 Oscar Health 并不在名单上。</p>
</div><p>While Oscar Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>尽管 Oscar Health 目前在分析师中获得了持有评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Oscar Health（NYSE:OSCR）创下 52 周新高 - 以下是原因